Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Intravenous Administration of IRX-010 in Healthy Participants
- First Posted Date
- 2024-04-10
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- ImmunoRx Pharma Inc.
- Target Recruit Count
- 83
- Registration Number
- NCT06356259
- Locations
- 🇳🇱
ICON, Groningen, Netherlands
News
No news found